Molecular diagnosis: Implications for ophthalmology

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The effort to subdivide diseases and to individualize therapies based on characteristics of the patient has been labeled precision medicine. Jameson and Longo define precision medicine as "treatments targeted to the needs of individual patients on the basis of genetic, biomarker, phenotypic or psychosocial characteristics that distinguish a given patient from other patients with similar clinical presentations" (Jameson and Longo, 2015). We illustrate how molecular diagnosis can be applied to orbital inflammatory disease to achieve the goals of precision medicine.

Original languageEnglish (US)
Pages (from-to)25-33
Number of pages9
JournalProgress in Retinal and Eye Research
Volume50
DOIs
StatePublished - Jan 1 2016

Fingerprint

Ophthalmology
Precision Medicine
Orbital Diseases
Biomarkers
Therapeutics

Keywords

  • Granulomatosis with polyangiitis
  • Molecular diagnosis
  • Nonspecific orbital inflammatory disease
  • Sarcoidosis
  • Thyroid eye disease
  • Transcriptomics

ASJC Scopus subject areas

  • Sensory Systems
  • Ophthalmology

Cite this

@article{02a7eac120aa44ceac357d7a1ffb3245,
title = "Molecular diagnosis: Implications for ophthalmology",
abstract = "The effort to subdivide diseases and to individualize therapies based on characteristics of the patient has been labeled precision medicine. Jameson and Longo define precision medicine as {"}treatments targeted to the needs of individual patients on the basis of genetic, biomarker, phenotypic or psychosocial characteristics that distinguish a given patient from other patients with similar clinical presentations{"} (Jameson and Longo, 2015). We illustrate how molecular diagnosis can be applied to orbital inflammatory disease to achieve the goals of precision medicine.",
keywords = "Granulomatosis with polyangiitis, Molecular diagnosis, Nonspecific orbital inflammatory disease, Sarcoidosis, Thyroid eye disease, Transcriptomics",
author = "Rosenbaum, {James (Jim)} and Cailin Sibley and Dongseok Choi and Harrington, {Christina (Chris)} and Stephen Planck",
year = "2016",
month = "1",
day = "1",
doi = "10.1016/j.preteyeres.2015.11.001",
language = "English (US)",
volume = "50",
pages = "25--33",
journal = "Progress in Retinal and Eye Research",
issn = "1350-9462",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Molecular diagnosis

T2 - Implications for ophthalmology

AU - Rosenbaum, James (Jim)

AU - Sibley, Cailin

AU - Choi, Dongseok

AU - Harrington, Christina (Chris)

AU - Planck, Stephen

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The effort to subdivide diseases and to individualize therapies based on characteristics of the patient has been labeled precision medicine. Jameson and Longo define precision medicine as "treatments targeted to the needs of individual patients on the basis of genetic, biomarker, phenotypic or psychosocial characteristics that distinguish a given patient from other patients with similar clinical presentations" (Jameson and Longo, 2015). We illustrate how molecular diagnosis can be applied to orbital inflammatory disease to achieve the goals of precision medicine.

AB - The effort to subdivide diseases and to individualize therapies based on characteristics of the patient has been labeled precision medicine. Jameson and Longo define precision medicine as "treatments targeted to the needs of individual patients on the basis of genetic, biomarker, phenotypic or psychosocial characteristics that distinguish a given patient from other patients with similar clinical presentations" (Jameson and Longo, 2015). We illustrate how molecular diagnosis can be applied to orbital inflammatory disease to achieve the goals of precision medicine.

KW - Granulomatosis with polyangiitis

KW - Molecular diagnosis

KW - Nonspecific orbital inflammatory disease

KW - Sarcoidosis

KW - Thyroid eye disease

KW - Transcriptomics

UR - http://www.scopus.com/inward/record.url?scp=84955265030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955265030&partnerID=8YFLogxK

U2 - 10.1016/j.preteyeres.2015.11.001

DO - 10.1016/j.preteyeres.2015.11.001

M3 - Article

C2 - 26608807

AN - SCOPUS:84955265030

VL - 50

SP - 25

EP - 33

JO - Progress in Retinal and Eye Research

JF - Progress in Retinal and Eye Research

SN - 1350-9462

ER -